You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聯合醫務(00722.HK)預計上半財年扭虧為盈至4900萬港元
格隆匯 02-11 16:53

格隆匯2月11日丨聯合醫務(00722.HK)公佈,董事會預期集團於截至2019年12月31日止六個月將錄得純利約4900萬港元,相比同期則錄得虧損淨額約1500萬港元。

2020財政年度上半年的純利較2019財政年度上半年所錄得的虧損淨額相對顯著增加,主要是由於根據認股權證文據之條款及條件向鄭和發行1.10億份公司認股權證而就此於2019財政年度上半年錄得4600萬港元的非現金以權益結算的股份支付開支,而2020財政年度上半年並無錄得此項目;及於2020財政年度上半年內錄得非現金以權益結算的股份支付開支之撥回約1500萬港元,原因為第二項及第三項歸屬里程碑之相關條款及條件並無在其於2019年11月14日屆滿前達成。

公司預期將錄得2020財政年度上半年收入約3.07億港元(2019財政年度上半年:2.62億港元)及2020財政年度上半年經調整EBITDA1約5000萬港元(2019財政年度上半年經調整EBITDA:3900萬港元),較去年同期分別增加約17%及28%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account